Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
Conditions: Colon Cancer Interventions: Drug: Serplulimab; Drug: Capecitabine; Drug: Oxaliplatin Sponsors: Ruijin Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Laparoscopic Right Hemicolectomy With Transrectal Specimen Extraction for Colon Cancer
Conditions: Colon Cancer Interventions: Procedure: Laparoscopic right hemicolectomy with transrectal specimen extraction Sponsors: National Cancer Center, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Metastatic Colorectal Cancer
Conditions: Metastatic Colon Cancer; Metastatic Rectum Cancer Interventions: Drug: Topical Tretinoin; Other: Placebo Sponsors: University of Utah Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform
Conditions: Metastatic Cancer; NSCLC Stage IV; Non-small Cell Lung Cancer Stage IV; Small Cell Lung Cancer Metastatic; Solid Tumor; Clear Cell Renal Cell Carcinoma Metastatic; Urothelial Carcinoma Bladder; Cutaneous Malignant Melanoma; Castration-resistant Prostate Cancer; Prostate Cancer Metastatic; TNBC - Triple-Negative Breast Cancer; Breast Cancer Stage IV; Colon Cancer Stage IV; MSI-H Cancer; Cervical Cancer Stage IV; Endometrial Cancer Stage IV; Mismatch Repair-Deficient Endometrial Endometrioid Adenocarcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Tissue Collection Sponsors: Mayo Clinic Not yet...
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Conditions: Cholangiocarcinoma; Multiple Myeloma; Colon Cancer; Rectal Cancer Interventions: Other: Return of Genetic Results: Biomarker information from cancer cells; Other: Return of Genetic Results: Inherited mutations related to cancer; Other: Return of Genetic Results: Inherited mutations related to other medical issues Sponsors: Washington University School of Medicine; National Cancer Institute (NCI); The Foundation for Barnes-Jewish Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors
Conditions: Breast Cancer; Colon Cancer Interventions: Device: Research-grade accelerometer; Other: National Comprehensive Cancer Network (NCCN) Education Materials; Device: Garmin Vivofit activity tracker; Other: Exercise Consultation Calls; Other: Interview; Other: Physical Activity Index Assessment (Intervention Arm); Other: Physical Activity Index Assessment (Control Arm); Other: Health Surveys Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Obstructive Colon Cancer, a Bridge to Surgery in Right Sided Obstructive Colon Cancer
Conditions: Colonic Neoplasms Malignant Sponsors: Amphia Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer
Conditions: Metastatic Colon Cancer Interventions: Drug: Serplulimab, mFOLFOX6 Sponsors: Henan Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Right Colectomy for Colon Cancer Database (RCC). Surgical Technique, Route of Access and Quality of the Specimen
Conditions: Right Sided Colon Cancer; Right Colectomy; Lymphadenectomy Interventions: Procedure: Surgical access Sponsors: Haukeland University Hospital; Intuitive Surgical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer
Conditions: Mindfulness; Colon Cancer; Females Interventions: Behavioral: Mindfulness Sponsors: University of Illinois at Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy
Conditions: Colorectal Cancer; Colonoscopy; Bowel Preparation Solution Interventions: Drug: Simethicone combined with Macrogol 4000 (PEG) Sponsors: Hospital St. Joseph, Marseille, France Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer
Conditions: Colon Cancer Interventions: Drug: Doublet or triplet chemotherapy combined with cetuximab Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Endoscopic Submucosal Dissection of Large Recto-sigmoid Lesions Under Spinal Anesthesia
Conditions: Colorectal (Colon or Rectal) Cancer Interventions: Procedure: ESD of large LSTs under SA Sponsors: Azienda USL Modena Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients
Conditions: Colon Cancer Interventions: Drug: Everolimus; Drug: PD-1 Sponsors: Fudan University; Anyang Tumor Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced But Resecable Colon Cancer in the Elderly of 70 Years Old or More
Conditions: Colon Cancer Interventions: Drug: Folfox; Procedure: Surgery Sponsors: Centre Hospitalier Universitaire Dijon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
